Literature DB >> 11809924

Silent mutations in secondary Shine-Dalgarno sequences in the cDNA of human serum amyloid A4 promotes expression of recombinant protein in Escherichia coli.

A Hrzenjak1, A Artl, G Knipping, G Kostner, W Sattler, E Malle.   

Abstract

The serum amyloid A (SAA) superfamily comprises a number of differentially expressed genes with a high degree of homology in mammalian species. SAA4, an apolipoprotein constitutively expressed only in humans and mice, is associated almost entirely with lipoproteins of the high-density range. The presence of SAA4 mRNA and protein in macrophage-derived foam cells of coronary and carotid arteries suggested a specific role of human SAA4 during inflammation including atherosclerosis. Here we underline the importance of ribosome binding site (rbs)-like sequences (also known as Shine-Dalgarno sequences) in the SAA4 cDNA for expression of recombinant SAA4 protein in Escherichia coli. In contrast to rbs sequences coded by the expression vectors, rbs-like sequences in the cDNA of target protein(s) are known to interfere with protein translation via binding to the small 16S ribosome subunit, yielding low or even no expression. Here we show that PCR mutations of two rbs-like sequences in the human SAA4 cDNA promote expression of considerable amounts of recombinant SAA4 in E.coli.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11809924     DOI: 10.1093/protein/14.12.949

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  6 in total

1.  Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.

Authors:  Suryakala Sarilla; Sally Y Habib; Douglas M Tollefsen; David B Friedman; Diana R Arnett; Ingrid M Verhamme
Journal:  Anal Biochem       Date:  2010-07-27       Impact factor: 3.365

2.  Combinatorial expression vector engineering for tuning of recombinant protein production in Escherichia coli.

Authors:  Nina Bandmann; Per-Ake Nygren
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

3.  Characterization of rat serum amyloid A4 (SAA4): a novel member of the SAA superfamily.

Authors:  Christine Rossmann; Christian Windpassinger; Daniela Brunner; Alenka Kovacevic; Natascha Schweighofer; Roland Malli; Rufina Schuligoi; Andreas Prokesch; Barbara Kluve-Beckerman; Wolfgang F Graier; Dagmar Kratky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem Biophys Res Commun       Date:  2014-07-17       Impact factor: 3.575

4.  Expression of serum amyloid A4 in human trophoblast-like choriocarcinoma cell lines and human first trimester/term trophoblast cells.

Authors:  C Rossmann; A Hammer; C N Koyani; A Kovacevic; M Siwetz; G Desoye; T G Poehlmann; U R Markert; B Huppertz; W Sattler; E Malle
Journal:  Placenta       Date:  2014-06-07       Impact factor: 3.481

5.  Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines.

Authors:  Alenka Kovacevic; Astrid Hammer; Elke Stadelmeyer; Werner Windischhofer; Monika Sundl; Alpana Ray; Natascha Schweighofer; Gerald Friedl; Reinhard Windhager; Wolfgang Sattler; Ernst Malle
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

6.  Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients.

Authors:  José A Fernández; Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2019-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.